3-(4-(5-methyl-1H-indazol-4-ylamino)pyrimidin-2-ylamino)benzenesulfonamide

ID: ALA248676

PubChem CID: 25138050

Max Phase: Preclinical

Molecular Formula: C18H17N7O2S

Molecular Weight: 395.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc2[nH]ncc2c1Nc1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1

Standard InChI:  InChI=1S/C18H17N7O2S/c1-11-5-6-15-14(10-21-25-15)17(11)23-16-7-8-20-18(24-16)22-12-3-2-4-13(9-12)28(19,26)27/h2-10H,1H3,(H,21,25)(H2,19,26,27)(H2,20,22,23,24)

Standard InChI Key:  ZKWWEOIHGRQYDB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
    2.5414   -4.5146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5402   -5.3423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2554   -5.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9721   -5.3419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9692   -4.5109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2536   -4.1016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6826   -4.0955    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3989   -4.5055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3986   -5.3286    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1141   -5.7385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8284   -5.3231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8226   -4.4934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1065   -4.0872    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1168   -6.5638    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8330   -6.9742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8323   -7.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5475   -8.2108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2578   -7.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5407   -6.5595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2580   -6.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8668   -6.4101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5256   -5.6591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.7062   -5.7516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1178   -8.2139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2552   -6.5812    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.2473   -7.4034    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0775   -6.5852    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4330   -6.5808    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 14 15  1  0
  5  7  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 19 15  1  0
 20 18  1  0
  7  8  1  0
 19 20  2  0
  3  4  2  0
  8  9  2  0
  1  2  2  0
  9 10  1  0
  4  5  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 19  1  0
 10 11  2  0
 16 24  1  0
  3 25  1  0
 11 12  1  0
  5  6  2  0
 12 13  2  0
 13  8  1  0
 25 26  1  0
  6  1  1  0
 25 27  2  0
 10 14  1  0
 25 28  2  0
M  END

Associated Targets(Human)

BTK Tclin Tyrosine-protein kinase BTK (8973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LYN Tclin Tyrosine-protein kinase Lyn (4251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TXK Tchem Tyrosine-protein kinase TXK (1590 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lck Tyrosine-protein kinase LCK (196 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.45Molecular Weight (Monoisotopic): 395.1164AlogP: 2.80#Rotatable Bonds: 5
Polar Surface Area: 138.68Molecular Species: NEUTRALHBA: 7HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 10.24CX Basic pKa: 4.28CX LogP: 2.65CX LogD: 2.64
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.41Np Likeness Score: -2.06

References

1. Bamborough P, Angell RM, Bhamra I, Brown D, Bull J, Christopher JA, Cooper AW, Fazal LH, Giordano I, Hind L, Patel VK, Ranshaw LE, Sims MJ, Skone PA, Smith KJ, Vickerstaff E, Washington M..  (2007)  N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics.,  17  (15): [PMID:17600705] [10.1016/j.bmcl.2007.04.029]

Source